Israel Englander’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Israel Englander’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,000	Closed	-$187K	–	4126
2016 Q4	$187K	Buy	+15,000	New	+$181K	﹤0.01%	3099
2016 Q3	–	Sell	-50,000	Closed	-$370K	–	3848
2016 Q2	$370K	Buy	+50,000	New	+$375K	﹤0.01%	2632

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Israel Englander's ARIA Position: Q1 2017 in Review

Israel Englander sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 250,925 shares — an estimated $3.12M sold.

Israel Englander first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $13.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Israel Englander reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Israel Englander sold 250,925 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $3.12M.
Israel Englander first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
Israel Englander's Ariad Pharmaceuticals Inc position peaked at $13.6M in Q1 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.